Related Experiment Videos

MPTP, MPP+ and mitochondrial function

Life Sciences
|February 23, 1987
PubMed

Insights

The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its metabolite 1-Methyl-4-phenylpyridinium (MPP+) impair mitochondrial function. This mitochondrial dysfunction is linked to the neurotoxic effects of MPTP-like compounds.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Toxicology

Background:

  • 1-Methyl-4-phenylpyridinium (MPP+) is the suspected toxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
  • MPTP is a known neurotoxin that selectively damages dopaminergic neurons.

Purpose of the Study:

  • To investigate the effects of MPTP and MPP+ on mitochondrial function and glycolysis.
  • To explore the role of mitochondrial Complex I and monoamine oxidase B (MAO-B) in MPTP toxicity.

Main Methods:

  • Assessing NAD(H)-linked mitochondrial oxidation in isolated mitochondria.
  • Measuring lactate production in mouse striatal slices to evaluate aerobic glycolysis.
  • Investigating the effects of MAO-B inhibition on MPTP-induced glycolysis.

Main Results:

  • MPP+ inhibited NAD(H)-linked mitochondrial oxidation at Complex I.
  • MPTP and MPP+ inhibited aerobic glycolysis in mouse striatal slices.
  • MPTP-induced glycolysis was prevented by MAO-B inhibition.
  • Neurotoxic MPTP analogs also inhibited mitochondrial oxidation.

Conclusions:

  • Compromise of mitochondrial oxidative capacity is a key mechanism in MPTP toxicity.
  • MPP+ mediated inhibition of Complex I contributes to neurotoxicity.
  • MAO-B activity is crucial for the neurotoxic effects of MPTP.

Related Concept Videos